Here is what market analysts said on today's market action: Siddhartha Khemka, Head - Retail Research, Motilal Oswal Financial Services “Domestic market cheered the regulatory approvals for domestic pharma companies to manufacture COVID-19 drugs and the global liquidity further provided support.
However, the global sentiments were weak as rising coronavirus cases in the US and Europe raised more doubts about a quick economic rebound.""Going ahead, we expect the markets to remain range-bound after the recent rally as the concerns remain over increasing infections both globally and domestically.
Investors would also track the ongoing situation of India and US with China. Thus we would advise investors to stay cautious while look for buying.